BREAKING NEWS: Charles (Chuck) Stark Named Regional Vice President for South Texas

Translate to Spanish or other 102 languages!

Charles (Chuck) Regional Vice President for South Texas
Charles (Chuck) Regional Vice President for South Texas

Mega Doctor News

- Advertisement -

Edinburg, Texas – South Texas Health System announced the appointment of Charles (Chuck) Stark to the position of Regional Vice President in South Texas effective June 29, 2018.  In this position, Stark will have regional responsibility for hospitals in the McAllen, Edinburg, Laredo, and Eagle Pass markets.

Prior to joining South Texas Health System, Stark served as Chief Executive Officer (CEO) of Brookwood Baptist Medical Center in Birmingham, Alabama, whose operations include a 645-bed acute care hospital specializing in heart and vascular services, women’s services, neurosciences and orthopedics, behavioral health and free-standing emergency department services.  He previously served in a number of leadership roles including President and CEO of Columbus Regional Health System (now Piedmont Columbus Regional) in Columbus, Georgia, President and CEO of Firelands Regional Health System in Sandusky, Ohio, and Senior Vice President of the Acute Care Division of HealthSouth Corporation (now Encompass Health) in Birmingham, Alabama.

Stark earned both his Bachelor of Science degree in Psychology and his Master’s Degree in Healthcare Administration from Duke University. “Chuck has extensive healthcare experience and a proven track record to help lead the South Texas market,” said Marvin Pember, Executive Vice President, UHS and President, Acute Care Division. “We are thrilled to bring his expertise to such growing and thriving markets.

- Advertisement -

“I’m looking forward to joining South Texas Health System,” said Stark. “I’m glad to be part of a progressive, patient-centered and quality focused organization.  I look forward to living in the beautiful Rio Grande Valley, assimilating with the warm friendly culture and becoming an active member of the South Texas communities.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.

STHS Scores Fourth Consecutive 5-Star Rating for Diabetic Care

Diabetes remains one of the nation’s most pressing health challenges, with a disease once largely associated with older adults now affecting younger populations at an alarming rate.
- Advertisement -